Literature DB >> 6892778

Selective binding of sucralfate to ulcer lesion. III. Experiments in rats with duodenal ulcer receiving 14C-sucralfate.

R Nagashima, Y Hinohara, T Hirano.   

Abstract

To determine whether the previously reported mechanisms of action of sucralfate for gastric ulcer are also operative in duodenal ulcer, a single dose of 14C-labelled sucralfate was administered orally to rats with acetic acid-induced duodenal ulcer. Adhesive coating with sucralfate was visible over the duodenal lesion for 6 h in the majority of animals and found localized increasingly selective to the ulcerous area following administration. Visual observations were supported quantitatively by greater than unity mean within-animal ulcer/non-ulcer ratios of binding by 14C-sucrose fulfate moiety and aluminum, with statistical significance at 3 and 6 h post-administration (P less than 0.01 or 0.05). While the aluminum component was found persistent relative to the sucrose sulfate moiety in the adhesive coating, an additional in vitro study revealed that this was due to the pH of duodenal contents and did not lead to a loss of adhesiveness. In addition to these results, the buffering potential of sucralfate coating to control the local pH condition sufficient for binding to ulcer surface proteins to occur support the conclusion that the same mechanisms of action of sucralfate commonly apply to gastric and duodenal ulcers.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6892778

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  6 in total

Review 1.  Current therapy in peptic ulcer.

Authors:  I N Marks
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

2.  A double-blind placebo controlled study to examine effects of sucralfate on paracetamol absorption.

Authors:  F Kamali; J R Fry; H L Smart; G D Bell
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

3.  New drugs for peptic ulcer.

Authors: 
Journal:  Br Med J       Date:  1980-11-08

Review 4.  Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

5.  Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats.

Authors:  S Okabe; K Takeuchi; H Kunimi; M Kanno; M Kawashima
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

6.  Selective binding of sucralfate to gastric ulcer in man.

Authors:  S Nakazawa; R Nagashima; I M Samloff
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.